ImmuneSensor Therapeutics

Private

Dallas, TexasHealthcare & Life Scienceshttps://www.immunesensor.com/

Last Round

Series A

Dec 5, 2022

Est. Valuation

$110M

Total Funding Raised

$26.1M

Company Overview

ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines targeting the cGAS-STING pathway to treat cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

cGAS-STING pathwaysmall molecule drugsbiotechdrug discoverycGAS inhibitorSTING agonistautoimmune disease therapyoncologyantibody drug conjugateADCclinical stage biotechinnate immunitytargeted therapypharma pipelinebiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImmuneSensor Therapeutics Comparables

Compare ImmuneSensor Therapeutics with similar companies based on industry and business-model similarity.

ImmuneSensor Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
IFM Therapeutics	86%
Roivant Sciences	78%
STINGINN, LLC	77%

View all Comparables

ImmuneSensor Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 5, 2022
Grant	Sep 20, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Tom Dubensky

President CEO

Executive Team

ImmuneSensor Therapeutics Investors

Notable investors and investment history

ImmuneSensor Therapeutics investors
Investor	Rounds
Cancer Prevention and Research Institute of Texas	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 20, 2022
$16.1M grant from Cancer Prevention and Research Institute of Texas.

View all signals

ImmuneSensor Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ImmuneSensor Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImmuneSensor Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDallas, Texas

Employee Range9

Year Founded2019

Last FundingDec 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.